Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 16, 2013, the Board of Directors (the "Board") of Allergan, Inc. ("Allergan") increased the size of the Board from 9 to 10 members and appointed Dr. Peter McDonnell to fill the resulting vacancy and serve as a member of the Board, effective as of January 31, 2013. Dr. McDonnell was also appointed to serve as a member of the Board's Corporate Governance and Compliance Committee and its Science and Technology Committee.

Dr. McDonnell will receive compensation in accordance with Allergan's current non-employee director compensation program, which was effective January 1, 2013, and pursuant to which Dr. McDonnell will receive a fixed annual value of approximately $450,000, comprised of (i) cash compensation for annual retainers and meeting fees with an approximate value of $100,000 and (ii) a targeted fixed annual equity award of approximately $350,000.

---